StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Oculis Holding AG
NasdaqGM:OCS
Sector
Location
Market Cap
USD 921.67 M
Share Price
USD 18.06
Avg Daily Volume
28,805
Change (1 day)
-1.85%
Change (1 year)
58.42%
Change (YTD)
6.24%
Oculis Holding AG Accounts Payable for the year ending December 31, 2024: USD 6.46 M
Oculis Holding AG Accounts Payable is USD 6.46 M for the year ending December 31, 2024, a -28.35% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Oculis Holding AG Accounts Payable for the year ending December 31, 2023 was USD 9.02 M, a 115.75% change year over year.
-
Oculis Holding AG Accounts Payable for the year ending December 31, 2022 was USD 4.18 M, a 363.00% change year over year.
-
Oculis Holding AG Accounts Payable for the year ending December 31, 2021 was USD 903.19 K, a 1.21% change year over year.
-
Oculis Holding AG Accounts Payable for the year ending December 31, 2020 was USD 892.38 K.
Competitors
Glaukos Corporation
USD 103.81
GKOS
-2.74
-2.57%
PharmaResearch Co., Ltd.
USD 405.60
214450.KQ
-1.12
-0.28%
Santen Pharmaceutical Co., Ltd.
USD 11.08
4536.T
-0.19
-1.66%
Bausch Health Companies Inc.
USD 6.41
BHC.TO
-0.24
-3.66%
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 7.45
300573.SZ
+0.08
1.14%
Ocular Therapeutix, Inc.
USD 11.03
OCUL
-0.05
-0.45%
Tarsus Pharmaceuticals, Inc.
USD 39.18
TARS
-1.98
-4.81%
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
Glaukos Corporation
USD 103.81
GKOS
-2.74
-2.57%
PharmaResearch Co., Ltd.
USD 405.60
214450.KQ
-1.12
-0.28%
Santen Pharmaceutical Co., Ltd.
USD 11.08
4536.T
-0.19
-1.66%
Bausch Health Companies Inc.
USD 6.41
BHC.TO
-0.24
-3.66%
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 7.45
300573.SZ
+0.08
1.14%
Ocular Therapeutix, Inc.
USD 11.03
OCUL
-0.05
-0.45%
Tarsus Pharmaceuticals, Inc.
USD 39.18
TARS
-1.98
-4.81%
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%